Tus-Pharmaceutical Group Co., Ltd. (000590.SZ)
CNY 7.98
(-0.25%)
CNY 7.98
(-0.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.39 Million | 54.47 Million | 25.19 Million | 51.48 Million | 29.2 Million | 654.23 Thousand |
| Net Income | 25.24 Million | 18.17 Million | 35.43 Million | 22.72 Million | 42.44 Million | -38.18 Million |
| Depreciation & Amortization | 28.25 Million | 24.35 Million | 19.48 Million | 14.17 Million | 14.33 Million | 16.07 Million |
| Deferred income taxes | -417.29 Thousand | 917.12 Thousand | -393.03 Thousand | -2.44 Million | 268.6 Thousand | 497.54 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -85.78 Million | 12.02 Million | -27.14 Million | 12.37 Million | -9.55 Million | 18.59 Million |
| Other non-cash items | 146.59 Million | -82.15 Thousand | -2.58 Million | 2.2 Million | -18 Million | 4.16 Million |
| Investing Cash Flow | 4.15 Million | -177.54 Million | -115.98 Million | -27.72 Million | 7.15 Million | 180.52 Million |
| Investments in PPE | -22.04 Million | -18.68 Million | -25.87 Million | -33.9 Million | -35.84 Million | -22.58 Million |
| Acquisitions | 1.2 Million | -214.51 Million | 2.71 Million | 200.2 Thousand | 47.06 Million | 9898.00 |
| Investment purchases | -391.9 Million | -826.5 Million | -1.09 Billion | -60 Million | -400 Thousand | -196.5 Million |
| Sales/Maturities of investments | 416.9 Million | 879.49 Million | 1 Billion | 60.38 Million | 1.93 Million | 396.59 Million |
| Other Investing Activities | 26.19 Million | 2.66 Million | -1.99 Million | 5.6 Million | -5.59 Million | 3.01 Million |
| Financing Cash Flow | -32.51 Million | 111.52 Million | -5.8 Million | 4.86 Million | -39.38 Million | 16.62 Million |
| Debt repayment | -25 Million | -18 Million | -5.05 Million | -5 Million | -38 Million | -12 Million |
| Dividends payments | -4.19 Million | -338.4 Thousand | -62.79 Thousand | -139.44 Thousand | -1.38 Million | -1.37 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.31 Million | 129.85 Million | -694.7 Thousand | 9.99 Million | -1.38 Million | 29.99 Million |
| Accounts receivables | -45.82 Million | 2.91 Million | -26.83 Million | -485.61 Thousand | -59.68 Million | 70.75 Million |
| Accounts payables | -28.31 Million | 15.51 Million | 35.65 Million | 15.68 Million | 32.83 Million | -46.1 Million |
| Inventory | -11.63 Million | -7.32 Million | -35.57 Million | -379.31 Thousand | 17.01 Million | -6.55 Million |
| Other working capital | -1.00 | 917.12 Thousand | -393.03 Thousand | -2.44 Million | 268.6 Thousand | 25.14 Million |
| Cash at beginning of period | 235.42 Million | 246.36 Million | 342.95 Million | 314.33 Million | 317.35 Million | 119.54 Million |
| Cash at end of period | 189.76 Million | 234.81 Million | 246.36 Million | 342.95 Million | 314.33 Million | 317.35 Million |
| Capital Expenditure | -22.04 Million | -18.68 Million | -25.87 Million | -33.9 Million | -35.84 Million | -22.58 Million |
| Effect of forex changes on cash | 11.09 Million | 0.60 | - | 0.86 | 14.69 | 27.67 |
| Net cash flow / Change in cash | -45.65 Million | -11.54 Million | -96.59 Million | 28.61 Million | -3.01 Million | 197.8 Million |
| Free Cash Flow | -50.43 Million | 35.78 Million | -679.27 Thousand | 17.57 Million | -6.63 Million | -21.93 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.05 Million | -15.11 Million | -8.28 Million | 18.81 Million | 25.24 Million | 47.6 Thousand |
| Depreciation & Amortization | - | 7.28 Million | 7.28 Million | 7.04 Million | 28.25 Million | -13.87 Million |
| Deferred income taxes | - | - | - | - | -417.29 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 26.05 Million | - | -49.5 Million | -85.78 Million | 29.65 Million |
| Other non-cash items | 6.96 Million | 76.79 Million | -33.88 Million | 15.56 Million | 146.59 Million | 3.31 Million |
| Investing Cash Flow | -28.64 Million | -23.9 Million | -2.95 Million | 48.9 Million | 4.15 Million | -61.53 Million |
| Investments in PPE | -18.74 Million | -3.95 Million | -3.3 Million | -7.1 Million | -22.04 Million | -6.7 Million |
| Acquisitions | 2000.00 | - | 350 Thousand | 1.01 Million | 1.2 Million | 21.33 Thousand |
| Investment purchases | -70 Million | -50 Million | -40 Million | -90 Million | -391.9 Million | -118.1 Million |
| Sales/Maturities of investments | 60.09 Million | 30.04 Million | 40 Million | 145 Million | 416.9 Million | 63.25 Million |
| Other Investing Activities | 2000.00 | -19.95 Million | 89.95 Thousand | 55.28 Million | 26.19 Million | 0.20 |
| Financing Cash Flow | 10.13 Million | -27.06 Million | 23.54 Million | -12.37 Million | -32.51 Million | -6.25 Million |
| Debt repayment | -11.52 Million | -25 Million | -24.73 Million | -9.89 Million | -25 Million | -5 Million |
| Dividends payments | -810.39 Thousand | -891.78 Thousand | -887.91 Thousand | -1.18 Million | -4.19 Million | -973.87 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -570.32 Thousand | -1.16 Million | -1.19 Million | -1.28 Million | -3.31 Million | -283.91 Thousand |
| Accounts receivables | - | 42.64 Million | - | -45.82 Million | -45.82 Million | 22.27 Million |
| Accounts payables | - | - | - | - | -28.31 Million | 425.72 Thousand |
| Inventory | - | -17.3 Million | - | -11.63 Million | -11.63 Million | 7.38 Million |
| Other working capital | - | 712.72 Thousand | - | 7.95 Million | -1.00 | -425.72 Thousand |
| Cash at beginning of period | 159.86 Million | 156.47 Million | 189.76 Million | 156.22 Million | 235.42 Million | 198.41 Million |
| Cash at end of period | 143.16 Million | 159.86 Million | 166.59 Million | 189.76 Million | 189.76 Million | 149.6 Million |
| Capital Expenditure | -18.74 Million | -3.95 Million | -3.3 Million | -7.1 Million | -22.04 Million | -6.7 Million |
| Effect of forex changes on cash | - | - | - | 5.09 Million | 11.09 Million | -150.83 Thousand |
| Net cash flow / Change in cash | -16.69 Million | 3.38 Million | -23.17 Million | 33.54 Million | -45.65 Million | -48.8 Million |
| Free Cash Flow | -16.83 Million | 50.44 Million | -45.47 Million | -15.18 Million | -50.43 Million | 12.43 Million |
MSBHF
THRD
600261
002176
ITE
WMLLF